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Abstract
Background: Nitric oxide sensitive guanylyl cyclase (NOsGC) is a heterodimeric enzyme formed by an a- and a b1-subunit. A
splice variant (C-a1) of the a1-subunit, lacking at least the first 236 amino acids has been described by Sharina et al. 2008 and
has been shown to be expressed in differentiating human embryonic cells. Wagner et al. 2005 have shown that the amino
acids 61–128 of the a1-subunit are mandatory for quantitative heterodimerization implying that the C-a1-splice variant
should lose its capacity to dimerize quantitatively.
Methodology/Principal Findings: In the current study we demonstrate preserved quantitative dimerization of the C-a1-
splice by co-purification with the b1-subunit. In addition we used fluorescence resonance energy transfer (FRET) based on
fluorescence lifetime imaging (FLIM) using fusion proteins of the b1-subunit and the a1-subunit or the C-a1 variant with
ECFP or EYFP. Analysis of the respective combinations in HEK-293 cells showed that the fluorescence lifetime was
significantly shorter (<0.3 ns) for a1/b1 and C-a1/b1 than the negative control. In addition we show that lack of the amino-
terminus in the a1 splice variant directs it to a more oxidized subcellular compartment.
Conclusions/Significance: We conclude that the amino-terminus of the a1-subunit is dispensable for dimerization in-vivo
and ex-vivo, but influences the subcellular trafficking.
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Introduction
Nitric oxide sensitive guanylyl cyclase is the physiological
receptor for nitric oxide (NO) and nitric oxide releasing drugs. Its
second messenger cyclic GMP is crucial for vasodilatation, penile
erection, platelet disaggregation and neurotransmission. The
heterodimeric enzyme is formed by either an a1-o ra na2-subunit
and a b1-subunit. Dimerization of the enzyme is a prerequisite for
its catalytic activity, because both the a- as well as the b1-subunit
provide essential residues for the conversion of GTP to cGMP [1].
There is conflicting evidence which parts of the subunits are
mandatory for quantitative heterodimerization. Previous studies
[2,3] show inconsistent results with respect to the requirement of
the a1 subunit amino-terminus which is missing in the naturally
occurring C-a1 splice variant [4]. Since the occurrence of this
splice variant has been linked to differentiation of human
embryonic stem cells [5], the capacity of the C-a1 splice variant
to heterodimerize and thus form a functionally active enzyme, is of
biological importance.
Because of the controversial nature of the question, we
investigated the dimerization capacity using two independent
experimental approaches. First we used a purification method of
the NOsGC b1-subunit and looked for co-purification of the a1
variants. With the second experimental approach we examined
fluorescence resonance energy transfer (FRET) based on fluores-
cence lifetime imaging (FLIM) in intact cells using fusion proteins
of the respective subunits with fluorescent proteins. While
analyzing the fluorescence lifetimes of the respective NOsGC-
subunits, we serendipitously discovered that the C-a1 splice
isoform, shows a unique subcellular distribution. Using a
fluorescent tagged marker for the endoplasmic reticulum (ER),
we conclude, that the C-a1 isoform is located at the ER. As it is
well known, that the redox state of the ER is relatively more
oxidized than the cytosol [6], we performed a ratiometric analysis
of the redox properties of the C-a1 protein by using a redox sensor
(Grx1-roGFP2) and identified, that the protein is not only
distributed in a different manner than the wild type, but also
located in a more oxidized environment. Co-expression of the b1-
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isoform, but led to a nuclear localization that was not found for the
canonical a1/b1 heterodimer. We could show that the C-a1 splice
isoform retains its ability to heterodimerize quantitatively with the
b1-subunit ex vivo and in intact cells, despite lack of amino-
terminal amino acids that were thought to be important for
heterodimerization [2]. In addition, we observed that the
fluorescent fusion of the C-a1 splice subunit is directed to a more
oxidized subcellular compartment, while the respective C-a1/b1
heterodimer shows a cytosolic and nuclear localization.
Results
a1DN259 will be expressed by the C-a1 splice form
Analyzing the C-a1 splice-variant described by Sharina et al. [4]
and designated a1DN240 shows that the first initiation codon after
splicing would either form an a1DN236 or an a1DN259 variant
because these represent the only methionines with an open reading
frame in the human sequence (Fig. 1 and Data S2). In a recently
published review by Sharina et al. 2011, the authors have adapted
our numbering [7]. In a previous study by Koglin and Behrends 2003
[3], we investigated intensely the a1DN236 truncation in compar-
ison to the a1DN259 truncation. Because neither enzyme activity,
substrate-dependency (GTP), nor dose-effect-curve of nitric oxide
differed significantly from a1DN259, it was suggested by the
reviewers to remove the redundant data for the a1DN236
truncation. Since there was no difference in molecular weight
between the a1DN236 and a1DN259 variant (Fig. 2), we now
assume that the recognition of the translation initiation site of
ATG259 is dominant over ATG236 in the human sequence. We
thus suggest that the C-a1 splice variant leads to the formation of a
subunit with an a1DN259 deletion.
Establishment of a novel one-step-purification protocol
We performed a new one-step-purification of the soluble
guanylyl cyclase using the Strep Tag II, which results in 1 mg
purified NOsGC from 1,000 ml Sf-9 culture medium. The yield
calculated by using the total activities of cytosol and purified
protein is <25 %. The purification factor is <125-fold and results
in a more than 95 % purity of the enzyme determined by
Coomassie stained gels.
Analysis of the heterodimerization of C-a1 by
co-purification with b1-S
Using a carboxy-terminally Strep tagged b1-subunit of NOsGC,
we could show that both a1-isoforms dimerize with the b1-subunit
(Fig. 3). Densitometric analysis and graphical representation as
described in [2] shows that C-a1 forms heterodimers not less but
more effectively with a relative value of 166.2 % (612.2 %)
compared with a1WT (Fig. 4). Alternatively the ratio of the band
intensities of the a1WT variants to the b1- bands were 0.7560.11
for C-a1/b1 and 0.4360.06 for a1/b1. The excess of the b1
subunit is due to the fact that purification was performed with a
Strep Tag II attached to the b1-subunit as described in [2]. Because
our findings contradict the central message of the paper by Wagner
at al. 2005 although the experimental approach was very similar
[2], we tested more subtle differences. We expressed Sf-9 cells
without any supplement, only with hemin (4 mg/l) and with both
hemin and lipid supplement as in [2], the latter being used to
reduce the shear forces during Sf-9 cell culture. After expression
under these conditions, we purified the enzyme complex and
performed a SDS-PAGE and the gel was stained with Coomassie
Blue according to the protocol by Kang et al. [8]. There was no
negative effect of either of the supplements on the heterodimer-
ization of C-a1/b1S (Fig. 5) confirming our finding that the C-a1
splice-variant retains its ability to heterodimerize under different
experimental conditions.
Guanylyl cyclase activity of the purified C-a1/b1 and a1/b1
heterodimers was measured under basal conditions, in the
presence of NO (100 mM DEA/NO) or in the presence of
10 mM cinaciguat. Consistent with the formation of more
functional heterodimers for C-a1/b1 versus a1/b1 in Sf-9 cell
culture, enzyme activity was higher for the splice variant under all
experimental conditions (Fig. 6). Spectroscopic analysis shows that
both C-a1/b1 than a1/b1 contain a significant amount of heme
(Fig. 7) which is consistent with their responsiveness to nitric oxide
(see Fig. 6).
Analysis of the heterodimerization of C-a1 by FLIM-FRET
In order to test whether the unexpected formation of more
functional heterodimers with the b1 subunit for C-a1 versus the
canonical a1 subunit is also seen in intact cells we used
fluorescence resonance energy transfer (FRET) based on fluores-
cence lifetime imaging. The a1-subunit and C-a1-subunit were
fused with ECFP and the b1-subunit with EYFP in analogy to a
previous FRET study by our group [9]. Analysis of the respective
combinations in HEK-293 cells showed that the fluorescence
lifetime was significantly shorter for a1/b1 and C-a1/b1 than the
negative control (Fig. 8A). This indicates that heterodimerization
of both a1 variants with the b1 subunit bring the respective fused
fluorescent proteins in a physical distance below 80 A ˚ [10]. As an
additional control, FLIM-FRET experiments were performed with
Figure 1. Assumed formation of a1DN259 deletion through C-a1 splice variant of guanylyl cyclase. The graphic is a modified version of
the domain architecture model by Derbyshire and Marletta [34].
doi:10.1371/journal.pone.0025772.g001
Dimerization of NOsGC
PLoS ONE | www.plosone.org 2 September 2011 | Volume 6 | Issue 9 | e25772constructs where the fluorescent proteins were exchanged (Fig. 8B).
Again there was evidence that the C-a1 splice variant and the
canonical a1-subunit heterodimerize equally well in intact cells.
The results are expressed as means 6 SEM of at least three
independent experiments. For minimum 20 cells were analyzed
each. All results were controlled for their statistical significance by
Student’s t-test. A value of p,0.01 was considered to be
statistically significant.
The magnitude of the change of the fluorescence-lifetime (<0.3
ns) was expected to prove an interaction.
Subcellular distribution of C-a1
While performing expression controls for the FLIM-FRET
experiments, we noticed a different subcellular localization of the
fluorescent fusion proteins of the C-a1 splice variant versus the
canonical a1 subunit each expressed in the absence of the b1-
subunit. Because of the granular perinuclear appearance of the
splice variant, we co-expressed human heme oxygenase 1 (HO-1)
with an amino-terminal ECFP as a well-known marker for the
endoplasmic reticulum [11] (Fig. 9A and B). While the C-a1 splice
variant showed an exact co-localization with HO-1, the canonical
a1 subunit showed a diverging homogenous distribution in the
cytosol (see Fig. 9A and B). Co-expression of untagged b1-subunit
led to a homogenous wild type like distribution of the C-a1 splice
variant with an additional nuclear signal in some (Fig. 9C, red
arrow) but not all cells (Fig. 9C, white arrow). Co-expression of
CFP-tagged b1-subunit (and omission of CFP-HO1) demonstrates
that expression of substantial amounts of the b1-subunit induces
this translocation to the nucleus (Fig. 9D, red arrow). In contrast,
no nuclear expression was detected for the canonical a1 subunit in
the presence of b1 (Fig. 9E).
Because Sharin et al. [5] have shown that the C-a1 splice variant
is ‘‘uniquely resistant to oxidative protein degradation’’ we
analyzed the redox-state of both a1 variants by fusion with the
redox-sensor Grx1-roGFP2. Ratiometric analysis showed no
difference between Grx1-roGFP2 (Fig. 10A) and a1-Grx1-roGFP2
(Fig. 10B). In contrast, C-a1-Grx1-roGFP2 showed a higher
ratiometric signal indicative of a more oxidized subcellular
environment (Fig. 10C). This effect was attenuated by co-
expression of the untagged b1-subunit (Fig. 10D). In contrast,
co-expression of untagged b1-subunit with a1-Grx1-roGFP2 led to
no change (Fig. 10E in comparison to Fig. 10B).
Discussion
It has recently been shown that the a1-subunit of the nitric oxide
receptor NOsGC undergoes splicing regulation in differentiating
human embryonic cells [5]. The results indicated high levels of an
amino-terminally deleted C-a1-splice form in differentiating cells
that showed a different intracellular distribution in comparison to
the canonical full-length a1-subunit. It has been published that the
amino-terminus of the a1-subunit is important for quantitative
dimerization with the b1-subunit [2]. This was in contrast to a
study where we had shown co-purification of the b1-subunit with
a1DN259 [3]. To explain the discrepancy, Wagner et al. [2] raised
the argument that we had applied a purification method, where we
pooled the fractions with catalytic activity [3]. Due to this
approach, it was conceivable, that only a small fraction which has
formed active heterodimers is considered, while non-heterodimer-
izing subunits are discarded. The present study circumvents this
potential problem by using a purification procedure based on an
affinity StrepTag attached to the b1-subunit in analogy to the
study of Wagner et al. [2]. Our results obtained by using co-
purification of the a1-subunit and the amino-terminally deleted C-
a1-splice form with the StrepTagged b1-subunit indicate that the
C-a1-splice form heterodimerizes quantitatively. Because of the
Figure 3. SDS-PAGE analysis of NOsGC variants. 5 mg of each
purified enzyme was electrophoretically separated by SDS-Page and
stained with Coomassie Blue. The experiments were repeated at least
three times and one representative result is shown. [molecular weights
predicted from their amino acid sequences: a1WT, 77.6 kDa; C-a1,
48 kDa; b1S, 72.2 kDa].
doi:10.1371/journal.pone.0025772.g003
Figure 2. Characterization of expression of the a1-subunits by
Western-blot analysis in cytosolic fractions of Sf-9c e l l s
infected with the respective variants of the a1-subunits. All
lanes were loaded with 40 mg protein of the cytosolic fractions. The
experiments were repeated at least three times and one representative
result is shown. [molecular weights predicted from their amino acid
sequences: a1WT, 77.6 kDa; a1DN236, 51.2 kDa; a1DN259, 48 kDa].
doi:10.1371/journal.pone.0025772.g002
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oxide sensitive guanylyl cyclase requires the a1 amino-terminus,
we used an additional method based on fluorescence resonance
energy transfer to demonstrate heterodimerization of the C-a1-
splice form with the b1-subunit in intact cells. This corroborated
our finding that lack of the amino-terminus of the a1-subunit does
not influence quantitative dimerization with the b1-subunit. This is
also consistent with a number of other studies [4,12,13,14]. Our
finding that a1-variants heterodimerize equally well in intact cells,
but the C-a1 splice form seems to lead to more intact heterodimers
upon purification is probably due to the greater stability of the
C-a1 splice variant [5]. This may also be the reason for the higher
enzyme activity of the C-a1/b1 heterodimer versus wild type.
Alternatively, it is conceivable, that the amino-terminal region
absent in C-a1 has a negative regulatory influence on basal activity.
This would be in line with a proposed regulatory domain-scale
mechanism of the amino-terminal domains of NOsGC [15] that are
in proximity to the catalytic domain [9]. The splice variant would
thus represent a disinhibited isoform under basal conditions.
Using fluorescent fusion proteins, we noticed a peculiar
localization of the C-a1-splice form compared to the wild type.
Comparison with fluorescent tagged heme oxygenase-1 which is
Figure 4. Densitometric analysis of dimerization. For quantification of the dimerization the optical densities of the Coomassie-stained bands
were measured. A: The values obtained for a1 were normalized to b1 in the same lane. Dimerization was calculated in percentage of a1WT/b1S. Data
are expressed as means 6 SEM.
doi:10.1371/journal.pone.0025772.g004
Figure 5. Coomassie staining of cytosolic fractions and purified proteins. 50 mg Cytosol of cytosolic fraction or 5 mg of purified enzyme was
electrophoretically separated by SDS-PAGE and stained with Coomassie Blue (a representative gel is shown). Lane A, cytosolic fraction of C-a1/b1S
expressed without heme-supplement and without lipid medium supplement. Lane B, purified C-a1/b1S expressed without heme-supplement and
without lipid medium supplement. Lane C, cytosolic fraction of C-a1/b1S expressed only with heme-supplement and without lipid medium
supplement. Lane D, purified C-a1/b1S expressed with heme-supplement and without lipid medium supplement. Lane E, cytosolic fraction of C-a1/b1S
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membrane [16], revealed a highly similar subcellular distribution.
As the endoplasmic reticulum shows a relatively oxidizing thiol-
disulfide milieu [17], we employed a novel method to measure the
glutathione redox potential based on a fusion of the a1-subunit in
its different splice forms with glutaredoxin-1 and roGFP2 [18].
This confirmed a more oxidizing thiol-disulfide milieu for the C-a1
splice variant compatible with localization at the endoplasmic
reticulum. Co-expression of the non-tagged b1-subunit changed
the subcellular localization as well as the thiol-disulfide milieu
signal for the C-a1-splice form but had no effect on the a1-subunit.
The finding that the a1/b1-heterodimer showed the expected
diffuse cytosolic localization, while the C-a1/b1-heterodimer was
also present in the nucleus, is interesting in the context of reports
suggesting a role for the b1-subunit in the nucleus: Baltrons and
colleagues have demonstrated that the b1-subunit translocates to
the nucleus for proteosomal degradation in rat astrocytes after
treatment with bacterial endotoxin [19]. In a subsequent report
the b1-subunit was shown to be peripherally associated to
chromosomes during mitosis and to play a role in chromatin
condensation and cell cycle progression in rat C6 glioma cells [20].
The mechanism by which the b1-subunit enters the nucleus is
unknown since the protein lacks a recognizable nuclear localiza-
tion signal [19]. However, it is conceivable that regions of the b1-
subunit that may be shielded in the classical a1/b1-heterodimeric
enzyme are exposed in the C-a1/b1-heterodimer and the b1-
homomer and are free to interact with proteins that regulate
nuclear import [21].
Sharin et al. have analyzed the subcellular distribution of the
native C-a1 splice form in differentiating human embryonic cells
Figure 6. Guanylyl cyclase activity of purified variants of the enzyme. Specific activity was measured under basal conditions (black column),
in the presence of 100 mM NO (DEA/NO, white column) and in the presence of 10 mM cinaciguat (gray columns). Data are expressed as means 6 SEM.
The experiments were repeated at least three times and one representative result is shown.
doi:10.1371/journal.pone.0025772.g006
Figure 7. Spectroscopic analysis of purified cGC enzyme complexes. Spectroscopic analysis shows absorption values at basal (solid line)o r
NO-stimulated (100 mM DEA/NO, dotted line) conditions. A: a1WT/b1S.B :C - a1/b1S.
doi:10.1371/journal.pone.0025772.g007
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detected in small amounts in the fraction containing nuclei and to
a greater extent in the cytosolic fraction [5]. This is consistent with
our findings for the overexpressed fluorescent tagged C-a1/b1-
heterodimer. Immunocytochemical analysis of differentiating
human embryonic cells at day 12 with an antibody that recognizes
both the a1-subunit and the C-a1 splice form showed a majority
(88 %) of cells with a diffuse staining indicative of a predominant
localization in the cytosol [5]. Again this is in line with our results
for the fluorescent tagged C-a1/b1-heterodimer and the fluores-
cent tagged a1/b1-heterodimer. In a minority of cells (12 %), a
filamentous staining was observed in human embryonic cells using
an antibody that recognizes both the a1-subunit and the C-a1
splice form. These cells were not analyzed for the b1-subunit
expression. So it remains a possibility that these cells do express no
or less b1-subunit. This would be consistent with our finding that
the fluorescently tagged C-a1 splice form shows a different
subcellular localization and redox environment alone than in the
presence of the b1-subunit.
The endoplasmic reticulum is involved in heme trafficking,
heme degradation and heme insertion into hemoproteins in
eukaryotic cells [22]. Biochemical analysis in native human
embryonic cells showed small amounts of the canonical a1-subunit
in the fraction containing the endoplasmic reticulum. The function
of the H-NOX domain of the a-subunits that is absent in the C-a1
splice variant is not clear. Very recently it has been suggested
based on overexpression and purification of the H-NOX-a1-
fragment in E. coli that it may bind heme via a non-covalent
interaction [23]. It is possible that the lack of this domain in the C-
a1 protein leads to trapping of the splice variant at the site of heme
insertion, while the canonical a1-subunit or the a1/b1-heterodimer
interacts only transiently with the endoplasmic reticulum e.g.
during heme insertion or maturation.
Sharina et al. showed that the C-a1 splice variant is more stable
in intact cells in the presence of ODQ, a well-known oxidant
[24] while the canonical a1-subunit is more rapidly degraded
under these conditions. We show in the current paper that
fluorescent labeled overexpressed C-a1 protein is targeted to a
more oxidized environment in comparison to the canonical a1-
subunit. Thus the higher stability of the C-a1 protein in the
presence of oxidants may represent an adaption to the redox
environment at the endoplasmic reticulum because it is well
known to be a more oxidized compartment than the cytosol [6].
NOsGC activators, like cinaciguat, which act at the H-NOX
domain of the b1-subunit enhance the stability of the protein
through inhibition of proteosomal degradation which can be
induced by oxidants like ODQ in the cell [25,26]. It is thus
conceivable that heme or ligand free H-NOX domains not only
of b1 but also of a1 subunits provide a signal that leads to more
rapid degradation.
In summary, we present evidence that the amino-terminal H-
NOX domain of the a1-subunit does not preclude quantitative
dimerization with the b1-subunit to form a stable active, heme




Cinaciguat (BAY 58-2667) was a generous gift from Johannes-
Peter Stasch (Bayer Pharma AG, Wuppertal, Germany). The Sf-9
cells were obtained from Invitrogen (Karlsruhe, Germany), the
HEK-293 cells were obtained from the German Collection of
Microorganisms and Cell Cultures (DSMZ) (Brunswick, Germany)
and the Sf-9 Easy Titer cell line (Sf-9ET) was a generous gift from
Dr. Dominic Esposito (National Institutes of Health, Rockville, USA).
D-desthiobiotin, avidin and Strep-TactinH SuperflowH high
capacity resin were purchased from IBA, Goettingen, Germany.
2-diethyl-1-nitroso-oxyhydrazine (DEA/NO), 2-(4-Hydroxyphe-
nylazo)benzoic acid (HABA), creatine kinase, hemin, lipid medium
supplement and all other chemicals, in the highest grade of
purity, were obtained from Sigma-Aldrich, Munich, Germany.
[a-
32P]GTP (400 Ci/mmol) was purchased from Hartmann
Figure 8. Fluorescence lifetimes of the FRET donor ECFP in HEK-293 cells, expressing donor only, and fluorescent tagged
heterodimeric NOsGC variants. Mean fluorescence lifetimes of ECFP were measured in HEK-293 cells at 37uC, 48 h post transfection with the
respective recombinant constructs. A: a1-variants as fluorescence-donor. B: a1-variants as fluorescence-acceptor. Data are presented in box and
whiskers plots showing the 25
th percentiles, 75
th percentile and median as box with the mean value as dotted line. Whiskers represent the 5
th and
95
th percentile, dots are outliers. Fluorescent tagged NOsGC variants show significantly reduced fluorescent lifetimes due to FRET.
doi:10.1371/journal.pone.0025772.g008
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mutagenesis, were obtained in HPLC purity grade from
biomers.net, Ulm, Germany.
Cloning of a1 Deletion Mutants
For construction of the a1DN236 mutant, a PvuII/HindIII
fragment of the a1 full-length (see ref. [3]) clone was ligated
StuI/HindIII into pFastBac
TM1vector (Invitrogen, Karlsruhe,
Germany). Cloning of the human amino-terminal deletion mutant
a1DN259 has been described previously [3].
Cloning of carboxy-terminal Strep Tag II b1-subunit (Sf-9
system)
For construction of the carboxy-terminal Strep Tag II with the b1-
subunitaPvuI/StuI fragment of the conjoined NOsGC constructb1a1-
Strep [27] was cloned using PvuI/SmaI into the pFastBac
TM1v e c t o r .
Figure 9. Expression of EYFP-marked a1 full-length (A) and C-a1 (B) in HEK-293 cells. As a marker of the endoplasmic reticulum [11]
ECFP tagged heme oxygenase 1 (human, HO-1) was co-transfected. A, a1 full-length shows cytosolic distribution. B, C-a1 shows a similar
distribution like ECFP-HO-1. C, addition of an untagged b1-subunit led in some cells a similar subcellular distribution as the wild type. The red
arrow denotes a cell likely co-transfected with b1, the white arrow denotes a cell likely not co-transfected with b1. D, only cells which express both
subunits show homogenous subcellular distribution. The red arrow denotes a cell co-transfected with b1, the white arrow denotes a cell not co-
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for determination of fluorescence lifetime
For construction of a1 full-length in pECFP-N1 (Clontech,
Mountain View, CA, USA) the a1 cDNA in pcDNA3.1/V5/His-
TOPO described by Haase et al. [27] was cloned HindIII/XhoI into
HindIII/SalI pECFP-N1. Cloning of the C-a1 (rat a1DN258) was
done by introduction of suitable restriction sites by site directed
mutagenesis into this construct, restriction and religation. At the
same time the Kozak consensus sequence [28] was optimized and a
start-methionine had to be introduced. For construction of C-a1-
ECFP the following primer pair was used: 59-GAA CCA GCC
CTA TTT GCT CGA GTC GGT CGC CAT GGA GAG CAC
CAA GCC TTC TCT-39 and 59-AGA GAA GGC TTG GTG
CTC TCCA TG GCG ACC GACT CG AGC AAA TAG GGC
TGG TTC-39. The initiation codons or complementary sequence
are bold type and the modified nucleotides are underlined. Using
the respective restriction sites in pECFP before the insert XhoI
digestion and religation led to C-a1-ECFP. Due to a slight
difference in the amino acid sequence rat a1DN258 correspond to
human a1DN259 (Data S1).
Cloning of b1 fused with EYFP for determination of
fluorescence lifetime
The cloning has been described previously [27].
Figure 10. Redox-state analysis of the a1 full-length and C-a1 in HEK-293 cells, using the redox-sensor Grx1-roGFP2. According to the
settings a higher value means a more oxidized state of the protein.
doi:10.1371/journal.pone.0025772.g010
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The carboxy-terminal ECFP-fusions of a1 full-length and C-a1
were exchanged for EYFP and the carboxy-terminal EYFP-fusion
of b1 was exchanged for ECFP using the pEYFP-N1 or pECFP-
N1 vector (Clontech) and AgeI/BsrGI as restriction enzymes.
Cloning of b1 in pcDNA3.1/V5/His-TOPO for Expression in
HEK-293-cells
The cloning has been described previously [27].
Cloning of ECFP-HO1 in pECFP-C1
The human heme oxygenase 1 (HO1) was amplified using the
primer pair (59-CCC AGC ACC GGC CGG ATG GAG-39/59-
TTC AGT GCC CAC GGT AAG GAA GC-39) und the
FirstChoice
TM PCR-Ready Human Placenta cDNA (Ambion,
Austin, USA). The PCR product was subcloned into pCRH2.1-
TOPOH vector. Through EcoRI/XbaI restriction the insertion into
pFastBac
TM1 was performed. Using EcoRI/KpnI the cDNA was
transferred into pECFP-C1 [29].
Cloning of Grx1-roGFP2-tagged a1 variants
Grx1-roGFP2 in pLPCX (Clontech) was a kind gift from Dr.
Tobias Dick (DKFZ, Heidelberg, Germany) [18]. Through
restriction with BglII/BsrGI the construct was ligated into
pEGFP-N1. Using SmaI/XbaI ECFP in a1-ECFP (s.a.) was
exchanged for Grx1-roGFP2 out of pLCPX (Eco47III/XbaI
restricted). After ApaI restriction and religation the frame was
restored.
Restriction of C-a1-EYFP and a1-Grx1-roGFP2 with Eco47III/
BstEII led to an exchange of the full-length construct for the splice
variant.
Control of sequences
All cloned constructs were verified by sequencing (GATC
Biotech, Konstanz, Germany).
Baculovirus Generation
Recombinant baculoviruses of respective subunits were gener-
ated using the Bac-to-BacH Baculovirus Expression System
(Invitrogen).
Sf-9 Cell Culture, Expression of Recombinant Guanylyl
Cyclase Subunits and Preparation of Cytosolic Fraction
Sf-9 cells were cultured in Sf-900
TM II serum-free medium
(Invitrogen) supplemented with 1 % penicillin/streptomycin (PAA
Laboratories, Coelbe, Germany) and 10 % fetal bovine serum
(Foetal Bovine Serum Gold, EU-approved, PAA Laboratories).
Spinner cultures were grown at 27uC at 140 rpm shaking on a
50 mm orbit platform and diluted to 2 N 10
6 cells/ml for infection.
500 ml of cell solution were infected with the respective
recombinant baculovirus stock with the multiplicities of infection
(MOI) of 1. The MOI was determined using Sf-9ET cell line
according to the recent published paper by Hopkins and Esposito
[30]. After 72 h cells were harvested by centrifugation (4,000 g for
1 min at 4uC). All following steps were performed on ice. The cell
pellet was resuspended in 30 ml of lysis buffer containing 50 mM
TEA-HCl, 1 mM EDTA, 10 mM dithiothreitol (DTT), 250 nM
Avidin, pH 7.4, and complete EDTA-free Protease Inhibitor
Cocktail Tablets (Roche, Mannheim, Germany). The cells were
lysed by sonication. Cytosolic fractions were obtained by
centrifugation for 180 min at 15,000 g at 4 uC. The cytosolic
fractions were filtered through a 0.2 mm syringe filter (Sartorius,
Goettingen, Germany). 2 ml aliquots of cytosolic fractions were
kept as reference for experiments to monitor the purification at all
steps. For investigation of the influence of heme supplement and
additionally of lipid medium supplement 4 mg/l hemin or/and 1
% lipid medium supplement were added.
One-Step-Purification of NOsGC
The purification was performed on ice or at 4uC. The
chromatographic step was performed on an A ¨KTApurifier 100
system (GE Healthcare, Munich, Germany). Cytosolic fractions
were immediately applied to a Strep-TactinH SuperflowH high
capacity resin (2 ml Volume in a Tricorn
TM 10/20 column) at
1 ml/min [31]. Buffer W contained 100 mM Tris-HCl, 1 M
NaCl, 1 mM EDTA, 1 mM benzamidine, 10 mM DTT, pH 8.0.
Buffer E was prepared by adding 2.5 mM D-desthiobiotin to
buffer W. The column was washed ad 1 ml/min with buffer W for
5 column volumes (CV). With 5 CV buffer E the elution of the
NOsGC was performed. Monitoring the absorbance at 254 nm,
280 nm and 430 nm showed a single peak in the fraction which
contained NOsGC. Regeneration of the column was performed by
15 CV buffer R (100 mM Tris-HCl, 150 mM NaCl, 1 mM
EDTA, 1 mM HABA, pH 8.0) at 1 ml/min and 8 CV of buffer
W at 1 ml/min The pooled fractions (approximately 15 ml) were
concentrated to a volume of about 500 ml using an Amicon Ultra-
15 centrifugal filter unit with 30 kDa cut-off (Millipore, Schwal-
bach, Germany).
Determination of Protein Concentration and Guanylyl
Cyclase Activity Assay
Protein concentrations were determined by the Warburg-Christian
method [32] using a NanoPhotometer
TM (Implen, Munich,
Germany). Guanylyl cyclase activity was measured as described
previously [3]. Purified NOsGC was diluted with 50 mM TEA-
HCl, 10 mM DTT, 1 mM EDTA, 0.5 mg/ml bovine serum
albumin (Roth, Karlsruhe, Germany), pH 7.4, quick-frozen in
liquid nitrogen with 10 % (v/v) glycerol and stored at -80uC.
Enzyme activity of purified protein (50 ng of protein per assay
tube) were determined by incubation for 10 min at 37uC in the
presence of 1 mM cGMP, 0.5 mM [a-
32P]GTP (about 0.2 mCi),
3 mM MgCl2, 50 mM TEA-HCl, pH 7.4, 0.25 g/liter creatine
kinase, 5 mM creatine phosphate, and 1 mM 3-isobutyl-1-
methylxanthine in a total volume of 100 ml as described by Schultz
and Boehme [33]. Reactions were started by the addition of protein
and incubation at 37uC. All experiments were stopped by ZnCO3
precipitation, and purification of the enzyme-formed cGMP was
performed as described previously. Basal enzyme activity mea-
surements were performed in the absence of NO or cinaciguat.
Measurements of stimulated enzyme were performed in the
presence of the NO donor DEA/NO or cinaciguat. DEA/NO was
dissolved in 10 mM NaOH, which did not affect the enzyme
activity (data not shown). Cinaciguat was dissolved in 100 %
DMSO and then diluted in distilled water to a final concentration
of 10 mM so that the final DMSO concentration in the enzyme
assay did not exceed 2.5% (v/v). At this concentration no effects of
DMSO on enzyme activity were observed (data not shown).
SDS-polyacrylamide electrophoresis gels and
immunoblot analysis
Aliquots of 50 mg (cytosolic fractions) or 5 mg (purified enzyme)
protein were heated for 3 min at 105uC with lidheat of 120uC
(PCR-Cycler) in a modified Laemmli sample buffer (50 mM Tris-
HCl, 1% SDS, 100 mM DTT, 30% Glycerol, pH 7.5). After the
heat-incubation 1 ml of a blue sample puffer [10% (m/w)
bromophenol blue solved in the modified Laemmli buffer] were
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teins were stained according to Kang et al. 2002 [8]. As pro-
tein markers predominantly PageRuler
TM Prestained Protein
Ladder and PageRuler
TM Unstained Protein Ladder from
Fermentas (St. Leon-Rot, Germany) were used. For immunoblot-




Healthcare)]. The membrane was reversibly stained with Ponceau
S to evaluate the protein transfer. Unspecific binding sites were
saturated by immersing the membrane for 1 h at room
temperature in TBST (10 mM Tris-HCl, pH 8.0, 150 mM NaCl,
0.1% (v/v) Tween 20) containing 5% nonfat dry milk. The
following antibodies against the two NOsGC subunits were used
for detection: anti-a1 (1:5,000) (Sigma, G4280) or a1-1200
(1:1,000; as described in [3]) and anti-b1 (1:4,000) (Sigma,
G4530). Antibodies were incubated for 1 h in TBST-buffer at
room temperature. The membranes were washed three times for
10 min with TBST and subsequently incubated for 1 h with
horseradish-peroxidase-conjugated anti-rabbit IgG antibody
(1:2,000/Cell Signaling Technology, distributor: New England
Biolabs, Frankfurt am Main, Germany or 1:4,000/Sigma). After
three washes with TBST-buffer the membranes were processed
with the enhanced chemiluminescence western blotting detection
system according to the recommendations of the manufacturer
(Roche) and the signals were detected with a charge-coupled
device camera (Intas, Goettingen, Germany) or the membranes
were processed with ECL Western blotting detection system
according to manufacturer’s recommendations (Amersham Phar-
macia Biotech, Piscataway, USA).
Quantification of heterodimerization
For quantification of subunit interaction, the Coomassie stained
gels were either captured using a white trans-illuminator and a
charge-coupled device camera (HighRes, Intas) or scanned using
ScanMaker i900 (Microtek, Willich, Germany). The analysis was
done using LabImage 1D (Kapelan, Leipzig, Germany). For the
wild-typeofthehumana1-subunitandC-a1thedensitometricvalues
of a1 full-length and the truncation were normalized to the value of
b1 in the same lane and dimerization is given as a percentage of
a1WT dimerization, which was set to 100%. Western blots were
analyzed accordingly with similar results (data not shown).
Fluorescence Lifetime Imaging (FLIM) using a confocal
laser scanning microscope
Determination of fluorescence lifetime was done as described
previously [9]. For microscopy HEK-293 cells were seeded in 24-
well imaging plates with special glass bottom (zell-kontakt, Noerten-
Hardenberg, Germany; distributed by PAA Laboratories, Coelbe,
Germany) and transfected with the cDNA coding for the respective
constructs for the expression of fluorescent tagged NOsGC subunits
usingLipofectamin
TMLTX(Invitrogen).48 hposttransfectioncells
wereimagedat 37uC ona Nikon Ti-E microscope equippedwithan
incubation chamber (Okolab, Naples, Italy) using a 60-fold
immersion objective (NA 1.4, Nikon). For live cell imaging culture
medium was removed, cells were washed twice and supplemented
with Hank’s balanced salt solution.
Fluorescence decays were measured in cells expressing the
FRET donor alone (ECFP) using the vector pECFP-N1 (Clontech)
as a negative control. The rat a1-subunits, wild-type and amino-
terminal truncation are carboxy-terminally tagged with ECFP as
FRET donor and the rat b1-subunit is carboxy-terminally tagged
with FRET acceptor EYFP using the vector pEYFP-N1 (Clontech)
or vice versa. Images were collected using a 405 nm pulsed laser.
Emitted fluorescence signals were selected using a CFP bandpass
filter (475/20 nm). FLIM images in the time domain from
fluorescent cells were recorded with a 4 channel time gated
detection system (LiMo module, Nikon). The images were
2566256 pixels in size and the acquisition time was 5 min.
Localization of a1 constructs by confocal laser scanning
microscope
The cells were prepared as described above. Amino-terminally
ECFP-tagged heme oxygenase 1 (human, HO-1) was used as a
marker for the endoplasmic reticulum [11].
Analyzing the redox state of the C-a1 and the a1 wild
type protein
Using fusion proteins of the respective a1 isoforms with the redox
sensor Grx1-roGFP2 we performed a ratiometric measurement.
The cells were simultaneously excited with a 405 nm and a 488 nm
laser. The emission was collected by a GFP bandpass filter (525/
50 nm).Theratio ofthe405/488 emissioncorrespondstotheredox
state. A high value means a more oxidized state and vice versa.
Statistical analysis
The results are expressed as means 6 SEM of at least three
independent experiments. All results were controlled for their
statistical significance by Student’s t-test. A value of p,0.01 was
considered to be statistically significant.
Supporting Information
Data S1 Amino acid sequence alignment of human
(Accession number: NP_000847.2) and rat (Accession
number: NP_058786.2) a1-subunit to show sequence
differences (performed with ClustalW2 at www.ebi.
ac.uk). Gaps are marked.
(PDF)
Data S2 Nucleic acid sequence alignment (partly
shown) of human a1 full-length (GB: Y15723) and
both splice-variants C*-a1 (GB: BX649180)/C-a1 (GB:
AK226125) (performed with ClustalW2 at www.ebi.
ac.uk). Initiation codons are marked.
(PDF)
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